Cargando…

Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy

Alterations in the abundance or activities of alternative splicing regulators generate alternatively spliced variants that contribute to multiple aspects of tumor establishment, progression and resistance to therapeutic treatments. Notably, many cancer-associated genes are regulated through alternat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonomi, Serena, Gallo, Stefania, Catillo, Morena, Pignataro, Daniela, Biamonti, Giuseppe, Ghigna, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826442/ https://www.ncbi.nlm.nih.gov/pubmed/24285959 http://dx.doi.org/10.1155/2013/962038

Ejemplares similares

Alternative Splicing and Tumor Progression
por: Ghigna, Claudia, et al.
Publicado: (2008)

Sam68 regulates EMT through alternative splicing–activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene
por: Valacca, Cristina, et al.
Publicado: (2010)

HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition
por: Bonomi, Serena, et al.
Publicado: (2013)

Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer
por: Siegfried, Zahava, et al.
Publicado: (2013)

Alternative Splicing: Role in Cancer Development and Progression
por: Sette, Claudio, et al.
Publicado: (2013)

The alternative splicing factor Nova2 regulates vascular development and lumen formation
por: Giampietro, Costanza, et al.
Publicado: (2015)

Alternative Splicing and Cancer
por: Auboeuf, Didier, et al.
Publicado: (2012)

An Intricate Connection between Alternative Splicing and Phenotypic Plasticity in Development and Cancer
por: Biamonti, Giuseppe, et al.
Publicado: (2019)

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
por: Pradella, Davide, et al.
Publicado: (2017)

Alternative Splicing: Recent Insights into Mechanisms and Functional Roles
por: Ghigna, Claudia, et al.
Publicado: (2020)

Tuning of Alternative Splicing - Switch From Proto-Oncogene to Tumor Suppressor
por: Shchelkunova, Aleksandra, et al.
Publicado: (2012)

The Krebs Cycle Connection: Reciprocal Influence Between Alternative Splicing Programs and Cell Metabolism
por: Biamonti, Giuseppe, et al.
Publicado: (2018)

Diversification of the muscle proteome through alternative splicing
por: Nakka, Kiran, et al.
Publicado: (2018)

Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis
por: Di Matteo, Anna, et al.
Publicado: (2020)

A 2-nt RNA enhancer on exon 11 promotes exon 11 inclusion of the Ron proto-oncogene
por: MOON, HEEGYUM, et al.
Publicado: (2014)

Switched alternative splicing of oncogene CoAA during embryonal carcinoma stem cell differentiation
por: Yang, Zheqiong, et al.
Publicado: (2007)

Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas
por: LeFave, Clare V, et al.
Publicado: (2011)

Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1
por: Du, Jun-Xian, et al.
Publicado: (2021)

Splicing is an alternate oncogenic pathway activation mechanism in glioma
por: Siddaway, Robert, et al.
Publicado: (2022)

Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer
por: Lo, April, et al.
Publicado: (2022)

Relative strength of 5’ splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA
por: Choi, Namjeong, et al.
Publicado: (2021)

Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells
por: Oh, Jagyeong, et al.
Publicado: (2021)

Alternative Splicing in Oncogenic Kinases: From Physiological Functions to Cancer
por: Druillennec, Sabine, et al.
Publicado: (2012)

Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-Oncogene
por: Moon, Heegyum, et al.
Publicado: (2015)

Global Alternative Splicing Defects in Human Breast Cancer Cells
por: Oh, Jagyeong, et al.
Publicado: (2021)

Transcription of Satellite III non-coding RNAs is a general stress response in human cells
por: Valgardsdottir, Rut, et al.
Publicado: (2008)

Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial Cells
por: Belloni, Elisa, et al.
Publicado: (2019)

How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors
por: Wojtyś, Weronika, et al.
Publicado: (2023)

A missense MT-ND5 mutation in differentiated Parkinson Disease cytoplasmic hybrid induces ROS-dependent DNA Damage Response amplified by DROSHA
por: Pignataro, Daniela, et al.
Publicado: (2017)

Ion channel chameleons: Switching ion selectivity by alternative splicing
por: Hsu, Allen L., et al.
Publicado: (2023)

Genetic variations and alternative splicing: the Glioma associated oncogene 1, GLI1
por: Zaphiropoulos, Peter G.
Publicado: (2012)

Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors
por: Piekielko-Witkowska, Agnieszka, et al.
Publicado: (2010)

METTL3 regulates breast cancer-associated alternative splicing switches
por: Achour, Cyrinne, et al.
Publicado: (2023)

Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer
por: Li, Ling, et al.
Publicado: (2020)

Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment
por: Mogilevsky, Maxim, et al.
Publicado: (2018)

Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation
por: Jia, Rong, et al.
Publicado: (2019)

Switched alternative splicing events as attractive features in lung squamous cell carcinoma
por: He, Boxue, et al.
Publicado: (2022)

Small Molecule Amiloride Modulates Oncogenic RNA Alternative Splicing to Devitalize Human Cancer Cells
por: Chang, Jan-Gowth, et al.
Publicado: (2011)

Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer
por: Di Matteo, Anna, et al.
Publicado: (2023)

Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression
por: Feng, Haoran, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_agul41cj0ptvkgcobif8vu29ak